Oseltamivir Phosphate
Product Images NDC 53002-1387

3 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 53002-1387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A965bcca 70c8 4ec7 Bb0f Fd9d96b43a75 01

FDA Label Image

Label Image (Lbl530021387)

Label Image (Lbl530021387)
OSELTAMIVIR PHOSPHATE 75 mg capsules packaging label from RPK Pharmaceuticals, Inc. The label states a prescription-only drug with a dosage instruction to take one capsule twice daily for 5 days. The package contains 10 capsules. Additional label information includes lot number, expiration date, and storage instructions.*
FDA Label Image

Lbl530021710

Lbl530021710
OSELTAMIVIR PHOSPHATE 45MG capsules packaging label for 10 capsules by RPK Pharmaceuticals, Inc. It includes dosage instructions to take 1 capsule twice a day for 5 days or as directed, with a note about the drug being antiviral and caution to take with meals. The label also displays lot number, expiration date, NDC barcode, and space for clinic name and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.